TLDR Three new types of a skin blistering disease were found, caused by specific gene mutations.
Epidermolysis bullosa (EB) included a range of inherited blistering diseases affecting the skin and sometimes mucous membranes and other organs, classified into four main subtypes and over 30 clinical subtypes with mutations in at least 18 genes. This review highlighted three newly identified autosomal recessive variants of EB caused by mutations in DST-e, EXPH5, or ITGA3. It discussed the discovery of these genes, their clinical features, mutation databases, and skin pathology, emphasizing the importance of recognizing these new forms for better clinical evaluation and understanding of genotype-phenotype correlations in EB.
15 citations
,
July 2024 in “Current Issues in Molecular Biology” Understanding molecular processes in skin development is key to creating targeted treatments for skin disorders.
October 2023 in “bioRxiv (Cold Spring Harbor Laboratory)” Immune cells are essential for early hair and skin development and healing.
44 citations
,
January 2017 in “Journal of Investigative Dermatology” Mutations in the KLHL24 gene cause skin blistering in epidermolysis bullosa simplex.
9 citations
,
August 2024 in “International Journal of Molecular Sciences” Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.
January 2020 in “Medical journal of clinical trials & case studies” A 37-year-old male with severe skin and internal issues has a rare inherited skin condition called dystrophic epidermolysis bullosa.
97 citations
,
May 2019 in “Frontiers in Cell and Developmental Biology” Abnormal ECM and immune cell interactions can cause skin diseases.